High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 255 participants.

Also called NCT01077206

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 255 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01077206
Other papers using this trial's data
  • High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial Stroke, 2015-02 DOI, PubMed 25516195

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01077206. Randomized; triple masking; primary purpose prevention. Start 2010-09 (registry gives no type); primary completion 2013-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage
Acronym
HDS-SAH
Condition
Subarachnoid Hemorrhage
Intervention (Drug)
Simvastatin
Lead sponsor
Chinese University of Hong Kong (class: other)
Collaborator
Hong Kong Government (class: other government)

Record details

Record id
cardio:ct-nct01077206
Content hash
fdd60cb9a8cb404eb860179ebeb389ced84ddd006e3273eab7eb5424cbea1126